[1]
|
S. Kauffman, “Cell proliferation in the Mammalian Lung,” International Review of Experimental Pathology, Vol. 22, 1980, pp. 131-191.
|
[2]
|
R. Mason and M. Williams, “Type II Alveolar Epithelial Cells,” In: R. G. Crystal and J. B. West, Eds., The Lung: Scientific Foundations, Raven, New York, 1991, pp. 235-246.
|
[3]
|
A. Zagariya, R. Bhat, B. Uhal, et al., “Cell Death and Lung Cell Histology in Meconium Aspirated Newborn Lungs,” European Journal of Pediatrics, Vol. 159, No. 11, 2000, pp. 819-826. doi:10.1007/s004310000581
|
[4]
|
E. White, “Life, Death and the Pursuit of Apoptosis,” Genes & Development, Vol. 10, No. 1, 1996, pp. 1-15.
doi:10.1101/gad.10.1.1
|
[5]
|
R. Wang, G. Alam, A. Zagariya, et al., “Apoptosis of Lung Epithelial Cells in Response to TNFα Requires Angiotensin II Generation de novo,” Journal of Cellular Physiology, Vol. 185, No. 2, 2000, pp. 253-259.
doi:10.1002/1097-4652(200011)185:2<253::AID-JCP10>3.3.CO;2-R
|
[6]
|
A. Zagariya, S. Mungre, R. Lovis, et al., “Tumor Necrosis Factor Alpha Gene Regulation: Enchantment of C/ EBP?—Induced Activation by c-Jun,” Molecular and Cellular Biology, Vol. 18, No. 5, 1998, pp. 2815-2824.
|
[7]
|
R. Wang, A. Zagariya, E. Ang, et al., “FAS-Induced Apoptosis of Alveolar Epithelial Cells Requires ANG II Generation and Receptor Interaction,” American Journal of Physiology, Vol. 277, No. 6, 1999, pp. L1245-1250.
|
[8]
|
R. Wang, C. Ramos, I. Joshi, et al., “Human Lung Myofibroblast-Derived Inducers of Alveolar Epithelial Apoptosis Identified Angiotensin Peptides,” American Journal of Physiology, Vol. 277, No. 6, 1999, pp. L1158-1164.
|
[9]
|
D. Munzenmaier, “Greene Opposite Actions of Angiotensin II on Microvascular Growth and Arterial Blood Pressure,” Hypertension, Vol. 27, 1996, pp. 760-766.
|
[10]
|
T. Yamada, M. Horiuchi and V. Dzau, “Angiotensin Type 2 Receptor Mediates Programmed Cell Death,” Proceedings of the National Academy of Sciences, Vol. 93, No. 1, 1996, pp. 156-160. doi:10.1073/pnas.93.1.156
|
[11]
|
S. Kumar, “ICE-Like Proteases in Apoptosis,” Trends in Biochemical Sciences, Vol. 20, No. 5, 1995, pp. 198-202.
doi:10.1016/S0968-0004(00)89007-6
|
[12]
|
D. Nicholson, A. Ali, N. Thornberry, et al., “Identification and Inhibition of the ICE/CED-3 Protease Necessary for Mammalian Apoptosis,” Nature, Vol. 376, No. 6535, 1995, pp. 37-43. doi:10.1038/376037a0
|
[13]
|
L. Harrison-Bernard, L. Navar, H. Ho, G. Vinson and S. El-Dahr, “Immunohistochemical Localization of ANG II AT1 Receptor in Adult Rat Kidney Using a Monoclonal Antibody,” American Journal of Physiology, Vol. 273, No. 1, 1999, pp. F170-F177.
doi:10.1097/00004872-199816010-00014
|
[14]
|
R. Wang, A. Zagariya, O. Ibarra-Sunga, et al., “Angiotensin II Induced Apoptosis in Human and Rat Alveolar Epithelial Cells,” American Journal of Physiology, Vol. 276, No. 5, 1999, pp. L885-L889.
|
[15]
|
K. Lai, J. Leung, W. To, et al., “Gene Expression of the Rennin Angiotensin System in Human Kidney,” Journal of Hypertension, Vol. 16, No. 1, 1998, pp. 91-102.
|
[16]
|
P. Ponte, S. Ng, J. Engel, et al., “Evolutionary Conservation Is in the Untranslated Regions of Actin mRNAs: DNA Sequence of a Human ?-actin cDNA,” Nucleic Acids Research, Vol. 12, 1984, pp. 1687-1696.
doi:10.1093/nar/12.3.1687
|
[17]
|
S. Dimmeler, U. Rippmann, J. Weiland, et al., “Angiotensin II Induces Apoptosis of Human Endothelial Cells,” Circulation Research, Vol. 81, No. 6, 1996, pp. 970-976.
|
[18]
|
J. Kajstura, A. Cigola, P. Malhotra, et al., “Angiotensin II Induces Apoptosis of Adult Ventricular Myocytes in Vitro,” Journal of Molecular and Cellular Cardiology, Vol. 29, No. 3, 1997, pp. 859-870.
|
[19]
|
S. Dimmeler, S. Brinkmann and E. Neugebauer, “Endotoxin-Induced Changes of Endothelial Cell Viability and Permeability: Protective Effect of a 21-Aminosteroid,” European Journal of Pharmacology, Vol. 287, No. 3, 2005, pp. 257-261. doi:10.1016/0014-2999(95)00499-8
|
[20]
|
B. Grasp-Kraup, H. Ruttkay-Nedecky, H. Koudelka, et al., “In Situ Detection of Fragmented DNA Fails to Discriminate among Apoptosis, Necrosis and Autolytic Cell Death: A Cautionary Note,” Hepatology, Vol. 21, No. 5, 1995, pp. 1465-1468.
|
[21]
|
F. Lyall, F. Dornan, J. McQuen, et al., “Angiotensin II Increases Protooncogene Expression and Phosphoinisitide Turnover in Vascular Smooth Muscle Cells via the Angiotensin II AT1 Receptor,” Journal of Hypertension, Vol. 10, No. 1, 1992, pp. 1463-1469.
doi:10.1097/00004872-199210120-00005
|
[22]
|
H. Oskarsson and D. Heistad, “Oxidative Stress Produced by Angiotensin Too: Implications for Hypertension and Vascular Disease,” Circulation, Vol. 95, 1997, pp. 557- 559.
|
[23]
|
M. Jacobson, “Reactive Oxygen Species and Programmed Cell Death,” Trends in Biochemical Sciences, Vol. 21, No. 3, 1996, pp. 83-86.
|
[24]
|
R. Ross, “Cell Biology of Atherosclerosis,” Annual Review of Physiology, Vol. 57, 1995, pp. 791-804.
doi:10.1146/annurev.ph.57.030195.004043
|
[25]
|
F. Cambien, O. Poirier, L. Lecerf, et al., “Deletion Polymorphism in the Gene for Angiotensin-Converting Enzyme Is a Potential Risk Factor for Myocardial Infarction in Patients with Hypertention,” New England Journal of Medicine, Vol. 324, 1992, pp. 1098-1104.
|